MaaT Pharma Provides Third Quarter 2024 Business and Financial Results and Announces Management Changes
Completion of enrollment in the European Phase 3 clinical trial ARES designed to evaluate efficacy and safety of MaaT013 in the treatment of acute Graft-versus-Host Disease; topline results expected in…
Best Health Care ETFs: Top Biotech, Pharma And Medical Funds
Morsa Images/Getty Images If you’re looking to invest in the health care industry, buying a health care exchange-traded fund (ETF) is an easy way to get started without having to…